Skip to main content
Top
Published in: Supportive Care in Cancer 11/2007

01-11-2007 | Original Article

Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies

Authors: P. A. Fasching, F. Thiel, K. Nicolaisen-Murmann, C. Rauh, J. Engel, M. P. Lux, M. W. Beckmann, M. R. Bani

Published in: Supportive Care in Cancer | Issue 11/2007

Login to get access

Abstract

Goals of work

In gynecological oncology, there is growing interest in the use of complementary and alternative medicine (CAM) methods. The lack of data regarding side effects, the lack of any survival advantages, and the costs of these methods appear to have no influence on patients’ decisions on whether to use CAM. Our interest was to evaluate the association between CAM use and the patients’ quality of life/life satisfaction (QoL/LS).

Materials and methods

One thousand thirty women with breast cancer of gynecologic malignancies were asked to participate in this study, which included a questionnaire and a personal interview on CAM. User status was compared with the patient’s own description of her QoL/LS and with the cancer type.

Main results

CAM was used by 48.7% of all women (n = 502). Breast cancer patients stated that they used CAM in 50.1% and women with gynecological cancer in 44.0%. The use of mistletoe was widespread (77.3%) and was more often seen in breast cancer patients than in gynecological cancer patients (74.4% vs 67.0%). CAM users less frequently stated an overall deterioration of their health status (35.1%) compared to nonusers (50.1%). CAM use resulted in a stated improvement in family conditions (6%) in comparison with the nonusers (2%).

Conclusions

With regard to patients’ perception of health status, CAM use is associated with a better coping with their disease. Most other categories of LS are not affected by CAM use. Patient-oriented information comparing standard therapies with CAM methods should be made widely available, and patients’ expectations of CAM use should be discussed between the physician and the patient.
Literature
1.
go back to reference Astin JA (1999) Use of alternative medicine by women with breast cancer. N Engl J Med 341:1156, author reply 1156–1157PubMed Astin JA (1999) Use of alternative medicine by women with breast cancer. N Engl J Med 341:1156, author reply 1156–1157PubMed
2.
go back to reference Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data:1–19 Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data:1–19
3.
go back to reference Bertz J, Hentschel S, Hundsdörfer G, Kaatsch P, Katalinic A, Lehnert M, Schön D, Stegmaier C, Ziegler H (2004) Krebs in Deutschland (Cancer in Germany), 4th edn. Saarbrücken Bertz J, Hentschel S, Hundsdörfer G, Kaatsch P, Katalinic A, Lehnert M, Schön D, Stegmaier C, Ziegler H (2004) Krebs in Deutschland (Cancer in Germany), 4th edn. Saarbrücken
5.
go back to reference Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739PubMedCrossRef Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739PubMedCrossRef
6.
go back to reference Carlsson M, Arman M, Backman M, Flatters U, Hatschek T, Hamrin E (2004) Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care. Acta Oncol 43:27–34PubMedCrossRef Carlsson M, Arman M, Backman M, Flatters U, Hatschek T, Hamrin E (2004) Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care. Acta Oncol 43:27–34PubMedCrossRef
7.
go back to reference Carlsson M, Arman M, Backman M, Hamrin E (2001) Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine. Cancer Nurs 24:395–401PubMedCrossRef Carlsson M, Arman M, Backman M, Hamrin E (2001) Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine. Cancer Nurs 24:395–401PubMedCrossRef
8.
go back to reference Cassileth BR, Deng G (2004) Complementary and alternative therapies for cancer. Oncologist 9:80–89PubMedCrossRef Cassileth BR, Deng G (2004) Complementary and alternative therapies for cancer. Oncologist 9:80–89PubMedCrossRef
9.
go back to reference Chrystal K, Allan S, Forgeson G, Isaacs R (2003) The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 116:U296PubMed Chrystal K, Allan S, Forgeson G, Isaacs R (2003) The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 116:U296PubMed
10.
go back to reference Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, Zheng W (2004) Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 85:263–270PubMedCrossRef Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, Zheng W (2004) Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 85:263–270PubMedCrossRef
11.
go back to reference Drew AK, Myers SP (1997) Safety issues in herbal medicine: implications for the health professions. Med J Aust 166:538–541PubMed Drew AK, Myers SP (1997) Safety issues in herbal medicine: implications for the health professions. Med J Aust 166:538–541PubMed
12.
go back to reference Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575PubMedCrossRef Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575PubMedCrossRef
13.
go back to reference Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83:777–782PubMedCrossRef Ernst E, Cassileth BR (1998) The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 83:777–782PubMedCrossRef
14.
go back to reference Fasching PA, Nicolaisen-Murmann K, Lux MP, Bani M, Thiel F, Bender HG, Beckmann MW, Ackermann S (2007) Changes in satisfaction in patients with gynecological and breast malignancies: an analysis with the Socio-Economic Satisfaction and Quality of Life (SES-QOL) questionnaire. Eur J Cancer Care (in press) Fasching PA, Nicolaisen-Murmann K, Lux MP, Bani M, Thiel F, Bender HG, Beckmann MW, Ackermann S (2007) Changes in satisfaction in patients with gynecological and breast malignancies: an analysis with the Socio-Economic Satisfaction and Quality of Life (SES-QOL) questionnaire. Eur J Cancer Care (in press)
15.
go back to reference Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21:4027–4033PubMedCrossRef Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21:4027–4033PubMedCrossRef
16.
go back to reference Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376–387PubMedCrossRef Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376–387PubMedCrossRef
17.
go back to reference Kappauf H, Leykauf-Ammon D, Bruntsch U, Horneber M, Kaiser G, Buschel G, Gallmeier WM (2000) Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology. Support Care Cancer 8:314–322PubMedCrossRef Kappauf H, Leykauf-Ammon D, Bruntsch U, Horneber M, Kaiser G, Buschel G, Gallmeier WM (2000) Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology. Support Care Cancer 8:314–322PubMedCrossRef
18.
go back to reference Knobf MT, Pasacreta J (1999) Use of alternative medicine by women with breast cancer. N Engl J Med 341:1156–1157PubMed Knobf MT, Pasacreta J (1999) Use of alternative medicine by women with breast cancer. N Engl J Med 341:1156–1157PubMed
19.
go back to reference Lee MM, Chang JS, Jacobs B, Wrensch MR (2002) Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 92:1606–1609PubMedCrossRef Lee MM, Chang JS, Jacobs B, Wrensch MR (2002) Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 92:1606–1609PubMedCrossRef
20.
go back to reference Lutz S, Spence C, Chow E, Janjan N, Connor S (2004) Survey on use of palliative radiotherapy in hospice care. J Clin Oncol 22:3581–3586PubMedCrossRef Lutz S, Spence C, Chow E, Janjan N, Connor S (2004) Survey on use of palliative radiotherapy in hospice care. J Clin Oncol 22:3581–3586PubMedCrossRef
21.
go back to reference Marstedt G, Moebus S (2004) Inanspruchnahme alternativer Methoden in der Medizin. Robert-Koch-Insitut, Berlin Marstedt G, Moebus S (2004) Inanspruchnahme alternativer Methoden in der Medizin. Robert-Koch-Insitut, Berlin
22.
go back to reference Nicolaisen-Murmann K, Thiel F, Mohrmann S, Grünewald E, Ackermann S, Bender HG, Beckmann MW, Fasching PA (2005) Complementary and alternative Methods (CAM) in women with gynecologic and breast malignancies-a multicenter study estimating prevalence and motivation. Geburtshilfe Frauenheilkd 65:1–8CrossRef Nicolaisen-Murmann K, Thiel F, Mohrmann S, Grünewald E, Ackermann S, Bender HG, Beckmann MW, Fasching PA (2005) Complementary and alternative Methods (CAM) in women with gynecologic and breast malignancies-a multicenter study estimating prevalence and motivation. Geburtshilfe Frauenheilkd 65:1–8CrossRef
23.
go back to reference Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89:873–880PubMedCrossRef Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89:873–880PubMedCrossRef
24.
go back to reference Sprangers MA (2002) Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 41:229–237PubMedCrossRef Sprangers MA (2002) Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 41:229–237PubMedCrossRef
25.
go back to reference Sprangers MA, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA (2002) Assessing meaningful change in quality of life over time: a users’ guide for clinicians. Mayo Clin Proc 77:561–571PubMed Sprangers MA, Moinpour CM, Moynihan TJ, Patrick DL, Revicki DA (2002) Assessing meaningful change in quality of life over time: a users’ guide for clinicians. Mayo Clin Proc 77:561–571PubMed
26.
go back to reference Waldron D, O’Boyle CA, Kearney M, Moriarty M, Carney D (1999) Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol 17:3603–3611PubMed Waldron D, O’Boyle CA, Kearney M, Moriarty M, Carney D (1999) Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol 17:3603–3611PubMed
27.
go back to reference Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM (2002) Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 137:889–903PubMed Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM (2002) Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 137:889–903PubMed
28.
go back to reference Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D (2004) Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 90:408–413PubMedCrossRef Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D (2004) Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 90:408–413PubMedCrossRef
Metadata
Title
Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies
Authors
P. A. Fasching
F. Thiel
K. Nicolaisen-Murmann
C. Rauh
J. Engel
M. P. Lux
M. W. Beckmann
M. R. Bani
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0231-1

Other articles of this Issue 11/2007

Supportive Care in Cancer 11/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine